Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia. (Q53470106)

14 May 2018

title

Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia. (English)

1 reference

14 May 2018

main subject

multiple drug resistance

1 reference

1 reference

1 reference

Maslak P

1

1 reference

14 May 2018

Hegewisch-Becker S

series ordinal

2

1 reference

14 May 2018

Godfrey L

series ordinal

3

1 reference

14 May 2018

Andreeff M

series ordinal

4

1 reference

14 May 2018

publication date

1 September 1994

1 reference

14 May 2018

number of pages

10

1 reference

inferred from page(s)

published in

Cytometry

1 reference

14 May 2018

volume

17

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

84-93

1 reference

14 May 2018

High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-define proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Drug-resistant mutants of Chinese hamster ovary cells possess an altered cell surface carbohydrate component

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Patterns of anthracycline retention modulation in human tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Reduced permeability in CHO cells as a mechanism of resistance to colchicine

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Effects of verapamil on the cellular accumulation of daunorubicin in blast cells and on the chemosensitivity of leukaemic blast progenitors in acute myelogenous leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Expression of the multidrug resistance gene in myeloid leukemias.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Drug resistance: the clinical problem.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990170111

7 January 2021

Identifiers

DOI

10.1002/CYTO.990170111

1 reference

14 May 2018

1 reference

14 May 2018